Apomine

N/A

Report date: 2023/08/27 20:00:33
NME

Base Information

Drug NameApomine
Drug Alias NameAPB-231-A2SR-45023ASR-9223iSK&F-99085
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulantsBile acid receptor FXR modulators
TargetsBile acid receptor FXR
Therapy Area/IndicationsSolid tumoursOsteoporosis, PostmenopausalOsteoporosis +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenzyme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenzyme Corp
Active IndicationsN/A
Inactive IndicationsSolid tumoursOsteoporosis, PostmenopausalOsteoporosis +[6] 

Other Information

ATC CodeN/A
Related LinksN/A